PA(18:1(12Z)-O(9S,10R)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/8:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:1(9Z)-O(12,13))

[(2R)-3-(octanoyloxy)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C29H53O9P (576.3427)

PA(8:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(9Z)-O(12,13)/8:0)

[(2R)-2-(octanoyloxy)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C29H53O9P (576.3427)

PA(18:1(9Z)-O(12,13)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/8:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Sanggenol E

3,5,7,2,4-Pentahydroxy-8,5-diprenyl-3-geranylflavanone

C35H44O7 (576.3087)

Casearin T

C31H44O10 (576.2934)

Caseargrewiin C

C31H44O10 (576.2934)

A diterpenoid of the clerodane group isolated from the bark of Casearia grewiifolia and has been shown to exhibit antimalarial and antimycobacterial activity.

Kadcoccilactone I

(+)-Kadcoccilactone I

C31H44O10 (576.2934)

Kadcoccilactone H

(+)-Kadcoccilactone H

C31H44O10 (576.2934)

methyl-ent-15alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha-hydroxy-7alpha-propionylyloxykaur-16-en-19-oate|methyl-ent-15alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha-hydroxy-7alpha-propionylyloxykaur-16-en-19-oate

C26H44N10O5 (576.3496)

Leu Met Lys Asp Gly

C24H44N6O8S (576.2941)

Lys Glu Ser Thr Leu

C24H44N6O10 (576.3119)

SREVS

Ser Arg Glu Val Ser

C22H40N8O10 (576.2867)

1-Hydroxyvitamin D3 3-D-glucopyranoside

(5Z,7E)-(1S,3R)-9,10-seco-5,7,10(19)-cholestatrien-3-D-glucopyranoside

C33H52O8 (576.3662)

D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

OHOHA-PA

1-(9Z-octadecenoyl)-2-(4-hydroxy-7-oxo-5E-heptenoyl)-sn-glycero-3-phosphate

C28H49O10P (576.3063)

Superecdysone E

(20S,22R)-3beta-(2R-hydroxypropionyl)-20,22-acetonide-14alpha,25-dihydroxy-5beta-cholest-7-en-6-one

C33H52O8 (576.3662)

3beta,15alpha,16alpha,24alpha-tetrahydroxy25,26,27-trinor-16,24-cyclo-cycloart-7-en-23-one-3-O-beta-D-xylopyranoside

3beta,15alpha,16alpha,24alpha-tetrahydroxy25,26,27-trinor-16,24-cyclo-9beta,19-cyclo-lanost-7-en-23-one-3-O-beta-D-xylopyranoside

C32H48O9 (576.3298)

ST 27:2;O2;GlcA

(5Z,7E)-25-hydroxy-10-seco-5,7,10(19)-cholestatrien-3alpha-yl beta-D-glucopyranosiduronic acid

C33H52O8 (576.3662)

23,24-dihydrocucurbitacin A

C32H48O9 (576.3298)

3-[(21S,22S)-16-ethenyl-26-ethyl-4-hydroxy-12,17,21-trimethyl-11-(2-methylpropyl)-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

3-[(21S,22S)-16-ethenyl-26-ethyl-4-hydroxy-12,17,21-trimethyl-11-(2-methylpropyl)-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

C33H52O8 (576.3662)

Diosgenin 3-O-beta-D-glucoside is a sterol 3-beta-D-glucoside having diosgenin as the sterol component. It has a role as a metabolite. It is a sterol 3-beta-D-glucoside, a monosaccharide derivative, a hexacyclic triterpenoid and a spiroketal. It is functionally related to a diosgenin. It derives from a hydride of a spirostan. Disogluside is a natural product found in Allium rotundum, Allium narcissiflorum, and other organisms with data available. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent A sterol 3-beta-D-glucoside having diosgenin as the sterol component. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2]. Diosgenin glucoside, a saponin compound extracted from Trillium tschonoskii, provides neuroprotection by regulating microglial M1 polarization. Diosgenin glucoside protects against spinal cord injury by regulating autophagy and alleviating apoptosis [1][2].

PM060431

C32H48O9 (576.3298)

A natural product found in Streptomyces albus.

calcidiol 3-O-(beta-D-glucuronide)

C33H52O8 (576.3662)

A steroid glucosiduronic acid that is calcidiol in which the hydroxy hydrogen at position 3 has been replaced by a beta-D-glucuronyl residue.

calcidiol 25-O-(beta-D-glucuronide)

(2r,3r)-2-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl}-3,5,7-trihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C35H44O7 (576.3087)

n-[(1s,3r,4s,6r,7s,8r,13s,16s,17s,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,14-dien-16-yl]benzenecarboximidic acid

n-[(1s,3r,4s,6r,7s,8r,13s,16s,17s,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,14-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

n-[(1s,6r,7s,8r,10s,11r,13s,14r,15s,16s)-8-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-6,10,15-trimethyl-19-oxapentacyclo[13.3.2.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]icosa-3,17-dien-16-yl]benzenecarboximidic acid

n-[(1s,6r,7s,8r,10s,11r,13s,14r,15s,16s)-8-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-13-hydroxy-6,10,15-trimethyl-19-oxapentacyclo[13.3.2.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]icosa-3,17-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

(2s)-2,4,6,9-tetrahydroxy-2-[(2e,6e,10z)-12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5,7-dimethylphenalene-1,3-dione

C35H44O7 (576.3087)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

18-hydroxy-15-(5-hydroxy-4-oxopentan-2-yl)-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C32H48O9 (576.3298)

n-[6-(acetyloxy)-7-[1-(dimethylamino)ethyl]-15-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,13-dien-16-yl]benzenecarboximidic acid

C35H48N2O5 (576.3563)

2-[3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-3,5,7-trihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C35H44O7 (576.3087)

1-{11a-[(acetyloxy)methyl]-2-hydroxy-3',9a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-4-hydroxy-2,3,4-trimethylpentyl acetate

C33H52O8 (576.3662)

(4as,6r,8as)-4,8a-dimethyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-1,4a,5,6,7,8-hexahydronaphthalen-2-one

(4as,6r,8as)-4,8a-dimethyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-1,4a,5,6,7,8-hexahydronaphthalen-2-one

C27H44O13 (576.2782)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

(4ar,6r,8ar)-4,8a-dimethyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-1,4a,5,6,7,8-hexahydronaphthalen-2-one

C27H44O13 (576.2782)

atractyloside i

C27H44O13 (576.2782)

{"Ingredient_id": "HBIN017309","Ingredient_name": "atractyloside i","Alias": "NA","Ingredient_formula": "C27H44O13","Ingredient_Smile": "CC1=C(C(=O)CC2(C1CC(CC2)C(C)(C)OC3C(C(C(C(O3)CO)O)O)O)C)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "576.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14425","TCMID_id": "1981","TCMSP_id": "NA","TCM_ID_id": "6485","PubChem_id": "101831407","DrugBank_id": "NA"}

beauwalloside

C32H48O9 (576.3298)

{"Ingredient_id": "HBIN017673","Ingredient_name": "beauwalloside","Alias": "NA","Ingredient_formula": "C32H48O9","Ingredient_Smile": "CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC)O","Ingredient_weight": "576.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2190","TCMSP_id": "NA","TCM_ID_id": "6409;21740","PubChem_id": "56841099","DrugBank_id": "NA"}

(2s,3s)-2-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl}-3,5,7-trihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C35H44O7 (576.3087)

(1r,3r,5r,6ar,7r,8r,9s,10s,10ar)-1,3,10-tris(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl butanoate

C31H44O10 (576.2934)

(1r,3s,5s,6ar,7r,8r,9r,10s,10ar)-1,3,9-tris(acetyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 3-methylbutanoate

C31H44O10 (576.2934)

(1r,2s,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5s,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O9 (576.3298)

(3e)-1-[(1s,3r,4r,4as,8s,8as)-8-hydroxy-3-(2-hydroxypropan-2-yl)-5,8a-dimethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,4,4a,7,8-hexahydro-1h-naphthalen-1-yl]-4-(4-hydroxyphenyl)but-3-en-2-one

C31H44O10 (576.2934)

1,3,9-tris(acetyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 3-methylbutanoate

C31H44O10 (576.2934)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-10-(acetyloxy)-1,9-dibutoxy-5-methoxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate

C33H52O8 (576.3662)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(1's,2r,2'r,4's,5r,7's,8'r,9's,12'r,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(1's,2r,2'r,4's,5r,7's,8'r,9's,12'r,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

3-[(2s,3r,4s,6s)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-[(4e,6e,9z)-3-hydroxy-6,8,10,12-tetramethyloctadeca-4,6,9-trien-2-yl]pyran-2-one

C33H52O8 (576.3662)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,3,9-tris(acetyloxy)-10-hydroxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 3-methylbutanoate

C31H44O10 (576.2934)

4,9,13-tris(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl 2-methylbutanoate

C31H44O10 (576.2934)

(1s,3r,7r,10s,13s,14r,15s)-1,7-dihydroxy-17-[(1s,2s)-1-hydroxy-1-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]propan-2-yl]-9,9,14-trimethyl-5-oxo-4,8-dioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁸]icos-17-en-15-yl acetate

(1r,2s,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4r,5s,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O9 (576.3298)

n-[(3s,4r,7r,8r,9s)-7-hexyl-4,9-dimethyl-8-[(4-methylhexanoyl)oxy]-2,6-dioxo-1,5-dioxonan-3-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

C30H44N2O9 (576.3047)

C30H44N2O9 (576.3047)

(1s,3r,7r,10s,12r,13r,14s,15s,17r,18s,19s,21s)-1,12-dihydroxy-9,9,14,18-tetramethyl-19-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-15-yl acetate

(1s,3r,7r,10s,12r,13r,14s,15s,17r,18s,19s,21s)-1,12-dihydroxy-9,9,14,18-tetramethyl-19-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-15-yl acetate

C31H44O10 (576.2934)

n-{7-hexyl-4,9-dimethyl-8-[(4-methylhexanoyl)oxy]-2,6-dioxo-1,5-dioxonan-3-yl}-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

C30H44N2O9 (576.3047)

4,8,13-tris(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-9-yl 2-methylbutanoate

C31H44O10 (576.2934)

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-8,9,13-tris(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-4-yl (2r)-2-methylbutanoate

C31H44O10 (576.2934)

(6r)-6-[(1r,2r,3as,3bs,4s,8s,9ar,9bs,11ar)-2,4,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl acetate

(6r)-6-[(1r,2r,3as,3bs,4s,8s,9ar,9bs,11ar)-2,4,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl acetate

C32H48O9 (576.3298)

2'',7'',7'',11'',16''-pentamethyl-3',5''-dioxo-1',9'a-dihydrodispiro[cyclopropane-1,2'-imidazo[1,2-a]indole-9',14''-[6,15]dioxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan]-10''-yl acetate

C34H44N2O6 (576.3199)

(2r,3r,4s,5r,6r)-2-methyl-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-methyl-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

methyl (2r,3r,4s,4ar,6ar,6bs,8as,11r,12r,12as,14r,14ar,14bs)-3-(acetyloxy)-2,12,14-trihydroxy-8a-(hydroxymethyl)-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylate

methyl (2r,3r,4s,4ar,6ar,6bs,8as,11r,12r,12as,14r,14ar,14bs)-3-(acetyloxy)-2,12,14-trihydroxy-8a-(hydroxymethyl)-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylate

C33H52O8 (576.3662)

1-[1-(acetyloxy)ethyl]-4-methylidene-7-(2-methyloxiran-2-yl)-6-[(3-methylpentanoyl)oxy]-2-oxo-hexahydro-1h-inden-5-yl 4-(acetyloxy)-3-methylpent-2-enoate

C31H44O10 (576.2934)

15-(acetyloxy)-10-hydroxy-5-(methoxycarbonyl)-5,9-dimethyl-14-methylidene-2-(propanoyloxy)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-8-yl 2,3-dimethyloxirane-2-carboxylate

C31H44O10 (576.2934)

4,8a-dimethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-1,4a,5,6,7,8-hexahydronaphthalen-2-one

C27H44O13 (576.2782)

(1s,3r,7r,10s,12r,13r,14s,15s,17r,18s,19s,21s)-1,12-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-15-yl acetate

(1s,3r,7r,10s,12r,13r,14s,15s,17r,18s,19s,21s)-1,12-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-15-yl acetate

C31H44O10 (576.2934)

(1s,3r,5r,6as,7r,8s,9r,10r,10as)-1,3,9-tris(acetyloxy)-10-hydroxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 3-methylbutanoate

C31H44O10 (576.2934)

methyl 5,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O8 (576.3662)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2'r,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2'r,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O8 (576.3662)

(1s,3r,7r,10s,12r,13r,14s,15s,17r,18s,19s,21s)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-12-yl acetate

(1s,3r,7r,10s,12r,13r,14s,15s,17r,18s,19s,21s)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-12-yl acetate

6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-5,6-dihydro-2',20'-dioxaspiro[pyran-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaen-3'-one

C36H48O6 (576.3451)

(1''r,2''r,8''r,9's,9'as,10''s,11''r,12''s,16''s)-2'',7'',7'',11'',16''-pentamethyl-3',5''-dioxo-1',9'a-dihydrodispiro[cyclopropane-1,2'-imidazo[1,2-a]indole-9',14''-[6,15]dioxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan]-10''-yl acetate

(1''r,2''r,8''r,9's,9'as,10''s,11''r,12''s,16''s)-2'',7'',7'',11'',16''-pentamethyl-3',5''-dioxo-1',9'a-dihydrodispiro[cyclopropane-1,2'-imidazo[1,2-a]indole-9',14''-[6,15]dioxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan]-10''-yl acetate

C34H44N2O6 (576.3199)

10,22-dihydroxy-14-(hydroxymethyl)-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-9-yl acetate

C31H44O10 (576.2934)

(1s,3r,5r,6as,7r,8r,10s,10as)-1,3-bis(acetyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (3s)-3-hydroxyoctanoate

C32H48O9 (576.3298)

(1r,3s,4s,4's,5s,7r,8s,10s,13s,14s,16s,18s,19r,21r,22r)-8-(acetyloxy)-3,21-dihydroxy-4',5,5',5',19-pentamethyl-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-7-yl acetate

(1r,3s,4s,4's,5s,7r,8s,10s,13s,14s,16s,18s,19r,21r,22r)-8-(acetyloxy)-3,21-dihydroxy-4',5,5',5',19-pentamethyl-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-7-yl acetate

C32H48O9 (576.3298)

(1's,2s,5s,6r,10'z,12'z,14's,15's,16'z,19'r)-6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-5,6-dihydro-2',20'-dioxaspiro[pyran-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaen-3'-one

(1's,2s,5s,6r,10'z,12'z,14's,15's,16'z,19'r)-6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-5,6-dihydro-2',20'-dioxaspiro[pyran-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaen-3'-one

C36H48O6 (576.3451)

(1r,3s,7s,10r,12s,13s,14r,15r,17s,18r,19r,21r)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-12-yl acetate

(1r,3s,7s,10r,12s,13s,14r,15r,17s,18r,19r,21r)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-12-yl acetate

C31H44O10 (576.2934)

19-hydroxy-4,5,24,24-tetramethyl-22-oxo-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,20-pentaen-18-yl 2-(dimethylamino)-3-methylbutanoate

19-hydroxy-4,5,24,24-tetramethyl-22-oxo-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,20-pentaen-18-yl 2-(dimethylamino)-3-methylbutanoate

C34H44N2O6 (576.3199)

(1s,2s,4s,5r,8r,9s,10r,13r,15r)-8-[(2s,3r)-2,3-dimethyloxirane-2-carbonyloxy]-10,15-dihydroxy-5-(methoxycarbonyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl (2s,3r)-2,3-dimethyloxirane-2-carboxylate

(1s,2s,4s,5r,8r,9s,10r,13r,15r)-8-[(2s,3r)-2,3-dimethyloxirane-2-carbonyloxy]-10,15-dihydroxy-5-(methoxycarbonyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl (2s,3r)-2,3-dimethyloxirane-2-carboxylate

C31H44O10 (576.2934)

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4,8,9-tris(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-13-yl (2r)-2-methylbutanoate

C31H44O10 (576.2934)

(1s,3r,7r,10s,12r,13r,14s,15s,17r,18s,19s,21s)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-12-yl acetate

(1s,3r,7r,10s,12r,13r,14s,15s,17r,18s,19s,21s)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5-oxo-4,8,20-trioxahexacyclo[11.10.0.0³,⁷.0³,¹⁰.0¹⁴,²¹.0¹⁷,²¹]tricosan-12-yl acetate

C31H44O10 (576.2934)

2,4,6,9-tetrahydroxy-2-[12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5,7-dimethylphenalene-1,3-dione

C35H44O7 (576.3087)

(1r,2r,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O9 (576.3298)

n-[(1s,3r,4s,6r,7s,8r,15r,16r,17s,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-15-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,13-dien-16-yl]benzenecarboximidic acid

2,9,10-trihydroxy-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-13-en-8-one

C32H48O9 (576.3298)